Isis Initiates Phase 1 Clinical Trial of ISIS-FXIRx to Treat Clotting Disorders

Wednesday, February 2, 2011 1 min read

Key Takeaway: Isis Initiates Phase 1 Clinical Trial of ISIS-FXIRx to Treat Clotting Disorders